Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 2
2016 1
2017 2
2018 1
2019 4
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Mn-Rich MnSb2 Te4 : A Topological Insulator with Magnetic Gap Closing at High Curie Temperatures of 45-50 K.
Wimmer S, Sánchez-Barriga J, Küppers P, Ney A, Schierle E, Freyse F, Caha O, Michalička J, Liebmann M, Primetzhofer D, Hoffman M, Ernst A, Otrokov MM, Bihlmayer G, Weschke E, Lake B, Chulkov EV, Morgenstern M, Bauer G, Springholz G, Rader O. Wimmer S, et al. Adv Mater. 2021 Oct;33(42):e2102935. doi: 10.1002/adma.202102935. Epub 2021 Sep 1. Adv Mater. 2021. PMID: 34469013
Non-inferiority double-blind randomised controlled trial comparing gabapentin versus tramadol for the treatment of chronic neuropathic or mixed pain in children and adolescents: the GABA-1 trial-a study protocol.
Kaguelidou F, Le Roux E, Mangiarini L, Lundin R, de Leeuw TG, Della Pasqua O, Felisi M, Bonifazi D, Tibboel D, Ceci A, de Wildt SN, Alberti C; GAPP consortium. Kaguelidou F, et al. BMJ Open. 2019 Feb 20;9(2):e023296. doi: 10.1136/bmjopen-2018-023296. BMJ Open. 2019. PMID: 30787078 Free PMC article. Clinical Trial.
Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial.
de Leeuw TG, Mangiarini L, Lundin R, Kaguelidou F, van der Zanden T, Pasqua OD, Tibboel D, Ceci A, de Wildt SN; GAPP consortium. de Leeuw TG, et al. Trials. 2019 Jan 15;20(1):49. doi: 10.1186/s13063-018-3169-3. Trials. 2019. PMID: 30646965 Free PMC article.
16 results